Similar Papers

Paper Title
Journal
Date
Author
LIM domain only 2 induces glioma invasion via cytosolic p27(KIP1).
Cheol Gyu Park ... Hyunggee Kim
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | VOL. 37
Cheol Gyu Park, et. al.Cheol Gyu Park ... Hyunggee Kim
18 Sep 2015
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment
Ash A Alizadeh ... Ronald Levy
Blood | VOL. 118
Ash A Alizadeh, et. al.Ash A Alizadeh ... Ronald Levy
04 Aug 2011
Abstract 4385: Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1): A target for cancer therapeutic intervention
Praveen Jaiswal ... Nallasivam Palanisamy
Cancer Research | VOL. 79
Praveen Jaiswal, et. al.Praveen Jaiswal ... Nallasivam Palanisamy
01 Jul 2019
Autophagy-related gene LAPTM4B promotes the progression of renal clear cell carcinoma and is associated with immunity.
He Wang ... Qibo Wang
Frontiers in Pharmacology | VOL. 14
He Wang, et. al.He Wang ... Qibo Wang
02 Mar 2023
View more papers

More From: Translational oncology

Paper Title
Journal
Date
Author
miR-4537 curtails ferroptosis by targeting MIOX in renal cell carcinoma.
Hui Li ... Shilin Geng
Translational oncology | VOL. 56
Hui Li, et. al.Hui Li ... Shilin Geng
01 Jun 2025
Research progress on estrogen receptor-positive/progesterone receptor-negative breast cancer.
Zhengjia Lu ... Jia Ming
Translational oncology | VOL. 56
Zhengjia Lu, et. al.Zhengjia Lu ... Jia Ming
01 Jun 2025
A new dawn: Vitalising translational oncology research in Africa with the help of advanced cell culture models.
Stefanie Klima ... Iman Van Den Bout
Translational oncology | VOL. 56
Stefanie Klima, et. al.Stefanie Klima ... Iman Van Den Bout
01 Jun 2025
Mesenteric benign lymph node enlargement in colorectal cancer: Friend or foe?
Wang Junwei ... Zhou Xin
Translational oncology | VOL. 56
Wang Junwei, et. al.Wang Junwei ... Zhou Xin
01 Jun 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.